Search
for
Sort by
Research 871–900 of 1000+
- Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review
- Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Systemic-Onset Juvenile Idiopathic Arthritis with unusual Cutaneous Manifestation and peripheral eosinophilia: Case Report
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus
- Exploring Mast Cell–CD8 T Cell Interactions in Inflammatory Skin Diseases
- Immune-mediated Coombs negative intravascular haemolysis in systemic lupus erythematosus (SLE)
- The Anti-Muscle Atrophy Effects of Ishige sinicola in LPS-Induced C2C12 Myotubes through Its Antioxidant and Anti-Inflammatory Actions
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Response to Mounessa et al.’s “Commonly prescribed medications associated with alopecia’’
- Response to Weinstein’s “Reply of Increased risk of vitamin D deficiency and insufficiency in Black patients with central centrifugal cicatricial alopecia.”
- Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
- Particulate matter exposure induces maternal scalp hair loss after birth in C57/B6 mouse via alteration of inflammatory and apoptotic pathways
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- The anti-inflammatory and analgesic activities of 2Br-Crebanine and Stephanine from Stephania yunnanenses H. S.Lo
- Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study
- Trichoscopic Signs in Dermatomyositis, Systemic Lupus Erythematosus, and Systemic Sclerosis: A Comparative Study of 150 Patients
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- The systemic wrinkled skin phenotype involves aberrant expression and variation of genes related to the oxidative stress and extracellular matrix in Xiang pigs
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san